Ketamine News: PharmaTher Begins FDA Filing For KETARX Application, Stella Acquires Field Trip Assets

Specialty biotech company PharmaTher Holdings Ltd. PHRRF has filed a pre-submission facility correspondence in advance of its Abbreviated New Drug Application (ANDA) for its novel racemic ketamine KETARX to the FDA. The filing of the pre-submission correspondence is expected to help achieve an…#phrrf #ketarx #fda #pharmather #anesthesia #analgesia #pharmapatch #stella #reunionneurosciences #stellas
Source: Reuters: Health - Category: Consumer Health News Source Type: news